Stephen K. Brannan - 09 Sep 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Medical Officer
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 09 Sep 2022
Net transactions value: -$1,180,950
Form type: 4
Filing time: 12 Sep 2022, 16:25:37 UTC
Previous filing: 11 Aug 2022
Next filing: 12 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$36,350	+5,000	+33%	$7.27^*	20,000	09 Sep 2022	Direct
transaction	KRTX	Common Stock	Sale	$1,217,300	-5,000	-25%	$243.46	15,000	09 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-5,000	-41%	$0.000000	7,110	09 Sep 2022	Common Stock	5,000	$7.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022.
F2	This option vested as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of August 8, 2018.